A glossary created by H. Van De Waterbeemd of Roche to define terminology in the rapidly growing field of computational drug design. It aims to help medicinal chemists without formal training in the field grasp concepts and utilize findings. The dataset's specific size, format, and update frequency are not detailed.
Use Cases
- Standardizing communication in drug discovery projects based on defined terminology.
- Training new researchers in computational pharmacology based on foundational concepts.
- Developing educational materials or documentation for computational chemistry tools.
- Cross-referencing terms when reading computational drug design literature.
Strengths
- Authored by an expert from a major pharmaceutical organization (Roche).
- Addresses a specific knowledge gap for medicinal chemists entering computational fields.
Limitations
- Column-level documentation is absent; field semantics must be inferred after download.
- Row count is unknown, which may limit suitability assessment.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- H. Van De Waterbeemd, Roche (Switzerland)